Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
PTAB denies Celltrion’s patent challenge against Genentech
Americas
The Patent Trial and Appeal Board has rejected Celltrion’s challenge against a Genentech patent centring on a method of treating rheumatoid arthritis, stating that the challenged patent did not show any reasonable likelihood of being invalid.   7 March 2017
Americas
Law firm Cooley has hired Ryan Sansom as a partner to enhance its life sciences practice in Boston.   6 March 2017
English High Court grants Arrow declaration in Fujifilm v AbbVie
Biotechnology
The English High Court has ruled in favour of Fujifilm Kyowa Kirin Biologics in a case against AbbVie, granting Fujifilm an Arrow declaration allowing it to market a biosimilar of AbbVie’s Humira (adalimumab), a medication used to treat arthritis.   6 March 2017
Europe
The English High Court handed down a split decision on patentability in a dispute between Edwards Lifesciences and Boston Scientific over patents covering transcatheter heart valves.   6 March 2017
Americas
Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.   3 March 2017
Americas
Otsuka Pharmaceutical has agreed to acquire Neurovance, a privately held clinical stage pharma company.   3 March 2017
Americas
The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.   2 March 2017
Americas
A US court has granted Pfizer a temporary restraining order against a former employee for allegedly stealing trade secrets.   2 March 2017
Americas
Speciality pharmaceutical company Orexo has filed a complaint against Actavis and its parent company Teva for infringing patents protecting Orexo’s Suboxone and Subutex.   1 March 2017
Americas
The US Court of Appeals for the Federal Circuit has remanded a decision to the Patent Trial and Appeal Board concerning a dispute between LA Biomedical Research Institute and Eli Lilly.   1 March 2017